George J. Chang, MD, MS, MHCM, FACS, FASCRS, FSSO

Peer-Reviewed Articles

1. Sammour T, Chang GJ. Lateral Pelvic Lymph Node Dissection and Radiation Treatment for Rectal Cancer: Mutually Exclusive or Mutually Beneficial?. Ann Gastroenterol Surg 2(5):348-350, 2018. e-Pub 2018. PMID: 30238075.
2. Mason MC, Tran Cao HS, Awad SS, Farjah F, Chang GJ, Massarweh NN. Hospital Minimally Invasive Surgery Utilization for Gastrointestinal Cancer. Ann Surg 268(2):303-310, 2018. e-Pub 2017. PMID: 28498235.
3. Pacyna JE, Kim S, Yost K, Sedlacek H, Petereit D, Kaur J, Rapkin B, Grubb R, Paskett E, Chang GJ Sloan J, Basch E, Major B, Novotny P, Taylor J, Buckner J, Parsons JK, Morris M, Tilburt JC. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD. BMC Cancer 18(1):788, 2018. e-Pub 2018. PMID: 30081846.
4. Osborne EM, Eng C, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Nancy You YQ, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation. Am J Clin Oncol 41(7):632-637, 2018. e-Pub 2016. PMID: 27755060.
5. Sada YH, Tran Cao HS, Chang GJ, Artinyan A, Musher BL, Smaglo BG, Massarweh NN. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer. J Surg Res 226:15-23, 2018. e-Pub 2018. PMID: 29661280.
6. Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, You YN, Kozower BD, Greenberg CC, Schrag D, Venook A, McKellar D, Winchester DP, Chang GJ, Alliance for Clinical Trials in Oncology Network Cancer Surveillance Optimization Working Group. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. JAMA 319(20):2104-2115, 2018. PMID: 29800181.
7. Delitto D, George TJ, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. J Natl Cancer Inst 110(5):460-466, 2018. PMID: 29165692.
8. Patel A, Chang GJ, Wale A, Rutten H, Nicholls J, Hawkins M, Steele RJC, Marks J, Brown G. Intra-operative radiotherapy-creating new surgical boundries. Colorectal Disease, 2018. PMID: 29878668.
9. Patel A, Chang G, Wale A, Chong I, Rutten H, Nicholls J, Hawkins M, Steele RJC, Marks J, Brown G. Session 3: Intra-operative radiotherapy - creating new surgical boundaries. Colorectal Dis 20 Suppl 1:65-75, 2018. PMID: 29878668.
10. Paquette IM, Madoff RD, Sigurdson ER, Chang GJ. Impact of Proximal Vascular Ligation on Survival of Patients with Colon Cancer. Ann Surg Oncol 25(1):38-45, 2018. e-Pub 2016. PMID: 27942902.
11. Ali SM, Pawlik TM, Rodriguez-Bigas MA, Monson JRT, Chang GJ, Larson DW. Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis. Ann Surg Oncol 25(1):32-37, 2018. e-Pub 2017. PMID: 28224365.
12. Voong KR, Rashid A, Crane CH, Minsky BD, Krishnan S, Yao JC, Wolff RA, Skibber JM, Feig BW, Chang GJ, Das P. Chemoradiation for High Grade Neuroendocrine Carcinoma of the Rectum and Anal Canal. Am J Clin Oncol 40(6):555-560, 2017. PMID: 26237193.
13. Clarke CN, Lee MS, Wei W, Manyam G, Jiang ZQ, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Overman M, Mills GB, Maru D, Kopetz S. Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival. Ann Surg Oncol, 2017. e-Pub 2017. PMID: 28936799.
14. Carlos RC, Sicks JD, Chang GJ, Lyss AP, Stewart TL, Sung L, Weaver KE. Capacity for Cancer Care Delivery Research in National Cancer Institute Community Oncology Research Program Community Practices: Availability of Radiology and Primary Care Research Partners. J Am Coll Radiol, 2017. e-Pub 2017. PMID: 29055605.
15. Holliday EB, Hunt A, You YN, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Eng C, Koay EJ, Minsky BD, Taniguchi C, Krishnan S, Herman JM, Das P. Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. J Gastrointest Oncol 8(6):990-997, 2017. PMID: 29299359.
16. Cata JP, Guerra CE, Chang GJ, Gottumukkala V, Joshi GP. Non-steroidal anti-inflammatory drugs in the oncological surgical population: beneficial or harmful? A systematic review of the literature. Br J Anaesth 119(4):750-764, 2017. PMID: 29121285.
17. Ikoma N, You YN, Bednarski BK, Rodriguez-Bigas MA, Eng C, Das P, Kopetz S, Messick C, Skibber JM, Chang GJ. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. J Clin Oncol 35(23):JCO2016721464, 2017. e-Pub 2017. PMID: 28657814.
18. Sammour T, Price BA, Krause KJ, Chang GJ. Nonoperative Management or 'Watch and Wait' for Rectal Cancer with Complete Clinical Response After Neoadjuvant Chemoradiotherapy: A Critical Appraisal. Ann Surg Oncol 24(7):1904-1915, 2017. e-Pub 2017. PMID: 28324284.
19. Malakorn S, Sammour T, Bednarski B, You YN, Chang GJ. Three Different Approaches to the Inferior Mesenteric Artery during Robotic D3 Lymphadenectomy for Rectal Cancer. Ann Surg Oncol 24(7):1923, 2017. e-Pub 2017. PMID: 28213788.
20. Gunther JR, Chadha AS, Shin US, Park IJ, Kattepogu KV, Grant JD, Weksberg DC, Eng C, Kopetz SE, Das P, Delclos ME, Kaur H, Maru DM, Skibber JM, Rodriguez-Bigas MA, You YN, Krishnan S, Chang GJ. Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis. Adv Radiat Oncol 2(3):455-464, 2017. e-Pub 2017. PMID: 29114614.
21. Price BA, Bednarski BK, You YN, Manandhar M, Dean EM, Alawadi ZM, Bryce Speer B, Gottumukkala V, Weldon M, Massey RL, Wang X, Qiao W, Chang GJ. Accelerated Enhanced Recovery following Minimally Invasive Colorectal Cancer Surgery (RecoverMI): A Study Protocol for a Novel Randomised Controlled Trial. BMJ Open 7(7):e015960, 2017. e-Pub 2017. PMID: 28729319.
22. Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Das P, Eng C, Kopetz S, Wolff RA, Crane CH, Krishnan S, Minsky B, Hu CY, Nguyen S, Chang GJ. Oncologic and Functional Hazards of Obesity among Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. Am J Clin Oncol 40(3):277-282, 2017. e-Pub 2016. PMID: 27028350.
23. Malakorn S, Sammour T, Pisters LL, Chang GJ. Robotic Total Pelvic Exenteration. Dis Colon Rectum 60(5):555, 2017. PMID: 28383456.
24. Sturgeon JD, Crane CH, Krishnan S, Minsky BD, Skibber JM, Rodriguez-Bigas MA, Chang GJ, You YN, Eng C, Das P. Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum. Am J Clin Oncol 40(2):163-166, 2017. e-Pub 2014. PMID: 25222072.
25. Alawadi Z, Phatak UR, Hu CY, Bailey CE, You YN, Kao LS, Massarweh NN, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer 123(7):1124-1133, 2017. e-Pub 2016. PMID: 27479827.
26. Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractioned Accelerated Reirradiation for Rectal Cancer. An Analysis of Outcomes and Toxicity. Radiother Oncol 122(1):146-151, 2017. e-Pub 2017. PMID: 28057329.
27. Liu C, Eng C, Shen J, Lu Y, Yoko T, Mehdizadeh A, Chang GJ, Rodriguez-Bigas MA, Li Y, Chang P, Mao Y, Hassan MM, Wang F, Li D. Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer. Oncotarget, 2016.
28. de Rosa N, Rodriguez-Bigas MA, Chang GJ, Veerapong J, Borras E, Krishnan S, Bednarski B, Messick CA, Skibber JM, Feig BW, Lynch PM, Vilar E, You YN. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol, 2016. e-Pub 2016. PMID: 27432916.
29. Lynch PM, Morris JS, Wen S, Advani SM, Ross W, Chang GJ, Rodriguez-Bigas M, Raju GS, Ricciardiello L, Iwama T, Rossi BM, Pellise M, Stoffel E, Wise PE, Bertario L, Saunders B, Burt R, Belluzzi A, Ahnen D, Matsubara N, Bülow S, Jespersen N, Clark SK, Erdman SH, Markowitz AJ, Bernstein I, De Haas N, Syngal S, Moeslein G. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc 84(1):115-125.e4, 2016. e-Pub 2016. PMID: 26769407.
30. Shin US, Nancy You Y, Nguyen AT, Bednarski BK, Messick C, Maru DM, Dean EM, Nguyen ST, Hu CY, Chang GJ. Oncologic Outcomes of Extended Robotic Resection for Rectal Cancer. Ann Surg Oncol 23(7):2249-57, 2016. e-Pub 2016. PMID: 26856720.
31. Schwarz L, Aloia TA, Eng C, Chang GJ, Vauthey JN, Conrad C. Transthoracic Port Placement Increases Safety of Total Laparoscopic Posterior Sectionectomy. Ann Surg Oncol 23(7):2167, 2016. e-Pub 2016. PMID: 26903047.
32. Glasgow SC, Morris AM, Baxter NN, Fleshman JW, Alavi KS, Luchtefeld MA, Monson JR, Chang GJ, Temple LK. Development of The American Society of Colon and Rectal Surgeons' Rectal Cancer Surgery Checklist. Dis Colon Rectum 59(7):601-6, 2016. PMID: 27270511.
33. Yamasaki A, Mise Y, Mise Y, Lee JE, Aloia TA, Katz MH, Chang GJ, Lillemoe KD, Raut CP, Conrad C. Musical preference correlates closely to professional roles and specialties in operating room: A multicenter cross-sectional cohort study with 672 participants. Surgery 159(5):1260-8, 2016. e-Pub 2015. PMID: 26706609.
34. You YN, Skibber JM, Hu CY, Crane CH, Das P, Kopetz ES, Eng C, Feig BW, Rodriguez-Bigas MA, Chang GJ. Impact of multimodal therapy in locally recurrent rectal cancer. Br J Surg, 2016. e-Pub 2016. PMID: 26933792.
35. Massarweh NN, Artinyan A, Chang GJ. Neoadjuvant treatment for rectal cancer-A value-based proposition. J Surg Oncol, 2016. e-Pub 2016. PMID: 27111410.
36. Rickles AS, Dietz DW, Chang GJ, Wexner SD, Berho ME, Remzi FH, Greene FL, Fleshman JW, Abbas MA, Peters W, Noyes K, Monson JR, Fleming FJ, Consortium for Optimizing the Treatment of Rectal Cancer (OSTRiCh). High Rate of Positive Circumferential Resection Margins Following Rectal Cancer Surgery: A Call to Action. Ann Surg 262(6):891-8, 2015. e-Pub 2015. PMID: 26473651.
37. Patel S, Chang GJ. Primary Tumor Resection in Metastatic Colorectal Cancer: Please Pass the Salt. JAMA Oncol 1(9):1213-4, 2015. e-Pub 2015. PMID: 26378904.
38. Morris VK, Rashid A, Rodriguez-Bigas M, Das P, Chang GJ, Ohinata A, Rogers J, Crane C, Wolff RA, Eng C. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal. Oncologist 20(11):1247-52, 2015. e-Pub 2015. PMID: 26382740.
39. Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR, Maun D, Chang GJ, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H. Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA 314(13):1346-55, 2015. PMID: 26441179.
40. Massarweh NN, Haynes AB, Chiang YJ, Chang GJ, You YN, Feig BW, Cormier JN. Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough?. Ann Surg 262(2):312-20, 2015. PMID: 25185467.
41. Hu CY, Bailey CE, Chang GJ. Less Surgery, Improved Survival From Stage IV Colorectal Cancer?-Reply. JAMA Surg 150(8):819-20, 2015. e-Pub 2015. PMID: 26107989.
42. Steele SR, Chang GJ, Hendren S, Weiser M, Irani J, Buie WD, Rafferty JF, Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer. Dis Colon Rectum 58(8):713-25, 2015. PMID: 26163950.
43. Chen ZY, Raghav K, Lieu CH, Jiang ZQ, Eng C, Vauthey JN, Chang GJ, Qiao W, Morris J, Hong D, Hoff P, Tran H, Menter DG, Heymach J, Overman M, Kopetz S. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. Br J Cancer 112(6):1088-97, 2015. e-Pub 2015. PMID: 25688736.
44. Zheng Z, Jemal A, Lin CC, Hu CY, Chang GJ. Comparative Effectiveness of Laparoscopy vs. Open Colectomy Among Non-metastatic Colon Cancer Patients: An Analysis Using the National Cancer Data Base. J Natl Cancer Inst 107(3), 2015. PMID: 25663688.
45. Hu CY, Bailey CE, You YN, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ. Time Trend Analysis of Primary Tumor Resection for Stage IV Colorectal Cancer: Less Surgery, Improved Survival. JAMA Surg 150(3):245-51, 2015. PMID: 25588105.
46. Bailey CE, Tran Cao HS, Hu CY, Chang GJ, Feig BW, Rodriguez-Bigas MA, Nguyen ST, Skibber JM, You YN. Functional Deficits and Symptoms of Long-Term Survivors of Colorectal Cancer Treated by Multimodality Therapy Differ by Age at Diagnosis. J Gastrointest Surg 19(1):180-8, 2015. PMID: 25213581.
47. Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010. JAMA Surg 150(1):1-6, 2015. PMID: 25372703.
48. Kneuertz PJ, Chang GJ , Hu CY, Rodriguez-Bigas MA, Eng C, Vilar E, Skibber JM, Feig BW, Cormier JN, You YN. Overtreatment of Young Adults With Colon Cancer: More Intense Treatments With Unmatched Survival Gains. JAMA Surg 150(5):402-9, 2015. PMID: 25806815.
49. Bailey CE, Hu CY, You YN, Kaur H, Ernst RD, Chang GJ. Variation in Positron Emission Tomography Use After Colon Cancer Resection. J Oncol Pract 11(3):e363-72, 2015. PMID: 25852143.
50. Dineen S, Lynch PM, Rodriguez-Bigas MA, Bannon S, Taggart M, Reeves C, Modaro C, Overman M, Chang GJ, Skibber JM, You YN. A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer. J Natl Compr Canc Netw 13(7):865-72, 2015. PMID: 26150580.
51. Hyngstrom JR, Tzeng CW, Beddar S, Das P, Krishnan S, Delclos ME, Crane CH, Chang GJ, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: Ten-year institutional experience. J Surg Oncol 109(7):652-8, 2014. e-Pub 2014. PMID: 24510523.
52. Haynes AB, You YN, Hu CY, Eng C, Kopetz ES, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007. Cancer 120(8):1162-70, 2014. e-Pub 2014. PMID: 24474245.
53. Massarweh NN, Chiang YJ, Xing Y, Chang GJ, Haynes AB, You YN, Feig BW, Cormier JN. Association Between Travel Distance and Metastatic Disease at Diagnosis Among Patients With Colon Cancer. J Clin Oncol 32(9):942-8, 2014. e-Pub 2014. PMID: 24516014.
54. Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, You YN, Maru DM, Munsell MF, Clemons MV, Kopetz SE, Garrett CR, Shureiqi I, Delclos ME, Krishnan S, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial. Int J Radiat Oncol Biol Phys 88(2):301-5, 2014. e-Pub 2013. PMID: 24315563.
55. Phatak UR, Li LT, Karanjawala B, Chang GJ, Kao LS. Systematic review of educational interventions for ostomates. Dis Colon Rectum 57(4):529-37, 2014. PMID: 24608311.
56. Abbas MA, Chang GJ, Read TE, Rothenberger DA, Garcia-Aguilar J, Peters W, Monson JR, Sharma A, Dietz DW, Madoff RD, Fleshman JW, Greene FL, Wexner SD, Remzi FH, Consortium for Optimizing Surgical Treatment of Rectal Cancer. ConsoritumConsortium for Optimizing Surgical Treatment of Rectal Cancer. Optimizing rectal cancer management: analysis of current evidence. Dis Colon Rectum 57(2):252-9, 2014. PMID: 24401889.
57. Monson JR, Probst CP, Wexner SD, Remzi FH, Fleshman JW, Garcia-Aguilar J, Chang GJ, Dietz DW, Consortium for Optimizing the Treatment of Rectal Cancer (OSTRiCh). Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg 260(4):625-31; discussion 631-2, 2014. PMID: 25203879.
58. Eng C, Chang GJ, You YN, Das P, Rodriguez-Bigas M, Xing Y, Vauthey JN, Rogers JE, Ohinata A, Pathak P, Sethi S, Phillips JK, Crane CH, Wolff RA. The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal. Oncotarget 5(22):11133-42, 2014. PMID: 25373735.
59. Massarweh NN, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Cormier JN, Feig BW, Chang GJ. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol 32(27):2967-74, 2014. PMID: 25092785.
60. Abbott DE, Tzeng CW, Merkow RP, Cantor SB, Chang GJ, Katz MH, Bentrem DJ, Bilimoria KY, Crane CH, Varadhachary GR, Abbruzzese JL, Wolff RA, Lee JE, Evans DB, Fleming JB. The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma. Ann Surg Oncol 20 Suppl 3:S500-8, 2013. e-Pub 2013. PMID: 23397153.
61. Lee S, Reha JL, Tzeng CW, Massarweh NN, Chang GJ, Hetz SP, Fleming JB, Lee JE, Katz MH. Race Does Not Impact Pancreatic Cancer Treatment and Survival in an Equal Access Federal Health Care System. Ann Surg Oncol 20(13):4073-9, 2013. e-Pub 2013. PMID: 24002535.
62. Eng C, Chang GJ, You YN, Das P, Xing Y, Delclos M, Wolff RA, Rodriguez-Bigas MA, Skibber J, Ohinata A, Gould S, Phillips J, Crane CH. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Cancer 119(21):3769-75, 2013. e-Pub 2013. PMID: 24037775.
63. Badgwell B, Stanley J, Chang GJ, Katz MH, Lin HY, Ning J, Klimberg SV, Cormier JN. Comprehensive geriatric assessment of risk factors associated with adverse outcomes and resource utilization in cancer patients undergoing abdominal surgery. J Surg Oncol 108(3):182-6, 2013. e-Pub 2013. PMID: 23804149.
64. Russell MC, You YN, Hu CY, Cormier JN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Nelson H, Chang GJ. A Novel Risk-Adjusted Nomogram for Rectal Cancer Surgery Outcomes. JAMA Surg 148(8):1-9, 2013. e-Pub 2013. PMID: 23803722.
65. Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100(8):E1-E33, 2013. PMID: 23754654.
66. Overman MJ, Fournier K, Hu CY, Eng C, Taggart M, Royal R, Mansfield P, Chang GJ. Improving the AJCC/TNM Staging for Adenocarcinomas of the Appendix: The Prognostic Impact of Histological Grade. Ann Surg 257(6):1072-8, 2013. e-Pub 2012. PMID: 23001080.
67. Bowles TL, Hu CY, You NY, Skibber JM, Rodriguez-Bigas MA, Chang GJ. An individualized conditional survival calculator for patients with rectal cancer. Dis Colon Rectum 56(5):551-9, 2013. PMID: 23575393.
68. Hu CY, Xing Y, Cormier JN, Chang GJ. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival. Cancer 119(10):1900-7, 2013. e-Pub 2013. PMID: 23408226.
69. Monson JR, Weiser MR, Buie WD, Chang GJ, Rafferty JF, Buie WD, Rafferty J, Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 56(5):535-50, 2013. PMID: 23575392.
70. Chagpar R, Chiang YJ, Xing Y, Cormier JN, Feig BW, Rashid A, Chang GJ, You YN. Neuroendocrine Tumors of the Colon and Rectum: Prognostic Relevance and Comparative Performance of Current Staging Systems. Ann Surg Oncol 20(4):1170-8, 2013. e-Pub 2012. PMID: 23212760.
71. Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X. Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer. Br J Cancer 108(7):1508-14, 2013. e-Pub 2013. PMID: 23470470.
72. Mirnezami R, Chang GJ , Das P, Chandrakumaran K, Tekkis P, Darzi A, Mirnezami AH. Intraoperative radiotherapy in colorectal cancer: Systematic review and meta-analysis of techniques, long-term outcomes, and complications. Surg Oncol 22(1):22-35, 2013. e-Pub 2012. PMID: 23270946.
73. Greenberg CC, Wind JK, Chang GJ, Chen RC, Schrag D. Stakeholder engagement for comparative effectiveness research in cancer care: experience of the DEcIDE Cancer Consortium. J Comp Eff Res 2(2):117-25, 2013. PMID: 24236554.
74. Hsu C, Rashid A, Xing Y, Chiang YJ, Chagpar RB, Fournier KF, Chang GJ, You YN, Feig BW, Cormier JN. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype. J Surg Oncol 107(2):136-43, 2013. e-Pub 2012. PMID: 22767417.
75. Tzeng CW, Aloia TA, Vauthey JN, Chang GJ, Ellis LM, Feig BW, Curley SA, Skibber JM, Abdalla EK, You YN, Rodriguez-Bigas MA. Morbidity of Staged Proctectomy After Hepatectomy for Colorectal Cancer: A Matched Case-Control Analysis. Ann Surg Oncol 20(2):482-90, 2013. e-Pub 2012. PMID: 22932858.
76. Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Feig B, Nguyen S, Hu CY, Chang GJ. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum 56(2):135-41, 2013. PMID: 23303140.
77. Skinner HD, Crane CH, Garrett CR, Eng C, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Kelly P, Sandulache VC, Delclos ME, Krishnan S, Das P. Metformin use and improved response to therapy in rectal cancer. Cancer Med 2(1):99-107, 2013. e-Pub 2013. PMID: 24133632.
78. Boland GM, Chang GJ, Haynes AB, Chiang YJ, Chagpar R, Xing Y, Hu CY, Feig BW, You YN, Cormier JN. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer 119(8):1593-601, 2013. PMID: 23280510.
79. Agarwal A, Chang GJ, Hu CY, Taggart M, Rashid A, Park IJ, You YN, Das P, Krishnan S, Crane CH, Rodriguez-Bigas M, Skibber J, Ellis L, Eng C, Kopetz S, Maru DM. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer 119(24):4231-41, 2013. PMID: 24089344.
80. Phatak UR, Kao LS, You YN, Rodriguez-Bigas MA, Skibber JM, Feig BW, Nguyen S, Cantor SB, Chang GJ. Impact of Ileostomy-Related Complications on the Multidisciplinary Treatment of Rectal Cancer. Ann Surg Oncol 21(2):507-12, 2013. PMID: 24085329.

Invited Articles

1. Greenberg C, Chang GJ, Nelson H. Patient-centered outcomes research: is this really something new?. Bull Am Coll Surg 99(1):51-2, 2014. PMID: 24552033.
2. Bednarski BK, Chang GJ. Ultra-low anterior resection following neoadjuvant chemoradiation for rectal cancer: The end of the 1-cm rule?. Seminars in Colon and Rectal Surgery 24(3):159-163, 2013.

Editorials

1. Schumacher JR, Neuman HB, Chang GJ, Kozower BD, Edge SB, Yu M, Vanness DJ, Si Y, Jacobs EA, Francescatti AB, Spears PA, Havlena J, Adesoye T, McKellar D, Winchester D, Burnside ES, Greenberg CC, Alliance ACS-CRP CCDR Breast Cancer Surveillance Working Group. A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01). Ann Surg Oncol 25(9):2587-2595, 2018. PMID: 29777402.
2. Sammour T, Malakorn S, Bednarski BK, Kaur H, Shin US, Messick C, You YN, Chang GJ. Oncological Outcomes After Robotic Protectomy for Rectal Cancer: Analysis of a Prospective Database. Ann Surg 267(3):521-526, 2018. PMID: 27997470.
3. Bednarski BK, Slack RS, Katz M, You YN, Papadopolous J, Rodriguez-Bigas MA, Skibber JM, Matin SF,Chang GJ. Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial. Dis Colon Rectum 61(1):77-83, 2018. PMID: 29215474.
4. Chang GJ, Gonen M. Prognostic and Predictive Ability of Tumor Sidedness: Another Vexing Difference Between Localized and Advanced Colon Cancer. JAMA Oncol, 2017. PMID: 28594984.
5. Chang GJ. Selective Lateral Pelvic Lymph Dissection for Rectal Cancer. Ann Surg Oncol, 2017. PMID: 28956307.
6. Chang GJ. Can prognostic scoring tools predict treatment outcomes. Dis Colon Rectum 60(9):875-876, 2017. PMID: 28796723.
7. Malakorn S, Chang GJ. Treatment of Rectal Cancer in the East and West: Should it be different?. Surgery 162(2):315-316, 2017. PMID: 28619666.
8. Sammour T, Chang GJ. Lateral Node Dissection in Low Rectal Cancer: Time for a Global Approach?. Ann Surg 266(2):208-209, 2017. PMID: 28437315.
9. Chang GJ. Treatment of locally advanced rectal cancer: turning good rationale into good evidence?. Dis Colon Rectum 60(7):649-650, 2017. PMID: 28594712.
10. Sandhu L, Chang GJ. Which Surgical Approach Is Best for Management of Rectal Cancer?: Does the End Point Tell How It Ends?. JAMA Surg 152(4):e165659, 2017. PMID: 28196188.
11. Chang GJ. Simulating Watch and Wait for Rectal Cancer. Dis Colon Rectum 58(2):155-6, 2015. PMID: 25585071.
12. Chang GJ, Kopetz S. Coordination of Care in Colon Cancer. Cancer 121(18):3201-3202, 2015. PMID: 26043269.
13. Chang GJ, Greenberg CC, Kozower BD, Boughey JC, Francescatti A, Mckellar DP, Winchester DP. NCDB and ACS-CRP: Working together to develop risk-stratified strategies for surveillance. Bull Am Coll Surg 99(8):57-8, 2014. PMID: 25145051.
14. Chang GJ. 'Watch-and-wait' for rectal cancer: what's the way forward?. Oncology (Williston Park) 28(7):617-8, 2014. PMID: 25144283.
15. Krishnan S, Chang GJ. Kras mutations and rectal cancer response to chemoradiation- are we closer to personalization of therapy?. Ann Surg Oncol 20(11):3359-62, 2013. PMID: 23864308.
16. Chang GJ. Emphasizing Surgery for Colon Cancer. Dis Colon Rectum 56(7):805-7, 2013. PMID: 23739185.
17. Chang GJ. Challenge of Primary Tumor Management in Patients with Stage IV Colorectal Cancer. J Clin Oncol 30(26):3165-6, 2012. PMID: 22869881.

Books (edited and written)

1. Chang GJ. Rectal Cancer: Modern Approaches to Treatment. Springer Nature: Switzerland, 2018.
2. Chang GJ. Operative Standards for Cancer Surgery. Lippincott Williams & Wilkins: Philadelphia, PA, 2015.

Letters to the Editor

1. Sandhu L, Chang GJ. Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer. Ann Surg Oncol, 2018.